Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000538055 | SCV000648435 | likely benign | Brugada syndrome 8 | 2024-05-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002395428 | SCV002701567 | uncertain significance | Cardiovascular phenotype | 2022-10-02 | criteria provided, single submitter | clinical testing | The p.R483Q variant (also known as c.1448G>A), located in coding exon 4 of the HCN4 gene, results from a G to A substitution at nucleotide position 1448. The arginine at codon 483 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |